Marc P Windisch
Overview
Explore the profile of Marc P Windisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
987
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Gil D, Park H, Lee Y, Mun S, Shin Y, et al.
Hepatology
. 2023 Nov;
80(1):186-201.
PMID: 37976400
Background And Aims: HCV infection can be successfully managed with antiviral therapies; however, progression to chronic liver disease states, including NAFLD, is common. There is currently no reliable in vitro...
2.
Duraisamy G, Jo E, Huvarova I, Park K, Heger Z, Adam V, et al.
Heliyon
. 2022 Sep;
8(9):e10465.
PMID: 36110238
Ginsenosides are a class of natural steroid glycosides and triterpene saponins found in . After screening of a commercial ginsenoside compound library for low cellular cytotoxicity and the ability to...
3.
Besson B, Eun H, Kim S, Windisch M, Bourhy H, Grailhe R
Sci Rep
. 2022 Jun;
12(1):9987.
PMID: 35705637
Bioluminescence resonance energy transfer (BRET) saturation is a method of studying protein-protein interaction (PPI) upon quantification of the dependence of the BRET signal on the acceptor/donor (A:D) expression ratio. In...
4.
Ianevski A, Yao R, Simonsen R, Myhre V, Ravlo E, Kaynova G, et al.
iScience
. 2022 Apr;
25(4):104112.
PMID: 35402870
Broadly effective antiviral therapies must be developed to be ready for clinical trials, which should begin soon after the emergence of new life-threatening viruses. Here, we pave the way towards...
5.
ElHefnawi M, Jo E, Tolba M, Fares M, Yang J, Shahbaaz M, et al.
Virology
. 2022 Mar;
570:9-17.
PMID: 35338891
The repurposing of marketed drugs for new indications is an elegant strategy to quickly and cost-efficiently address unmet medical needs. The hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) has...
6.
Ezzemani W, Windisch M, Altawalah H, Guessous F, Saile R, Benjelloun S, et al.
J Biomol Struct Dyn
. 2022 Mar;
41(9):3762-3771.
PMID: 35318896
Zika virus (ZIKV), an RNA virus, rapidly spreads mosquito-borne sickness. Currently, there are neither effective vaccines nor therapeutics available to prevent or treat ZIKV infection. In this study, to address...
7.
Ianevski A, Yao R, Zusinaite E, Lello L, Wang S, Jo E, et al.
Viruses
. 2021 Dec;
13(12).
PMID: 34960758
Background: There is an urgent need for new antivirals with powerful therapeutic potential and tolerable side effects. Methods: Here, we tested the antiviral properties of interferons (IFNs), alone and with...
8.
Jo E, Kim H, Konig A, Yang J, Yoon S, Windisch M
Antiviral Res
. 2021 Nov;
196:105195.
PMID: 34736995
The quantification of infectious virus particles is fundamental to perform in vitro virology studies. To determine the number of hepatitis B virus (HBV) genome-containing particles in vitro, the genome equivalents...
9.
Ko M, Chang S, Byun S, Ianevski A, Choi I, DOrengiani A, et al.
Viruses
. 2021 Apr;
13(4).
PMID: 33918958
Therapeutic options for coronaviruses remain limited. To address this unmet medical need, we screened 5406 compounds, including United States Food and Drug Administration (FDA)-approved drugs and bioactives, for activity against...
10.
Genera M, Quioc-Salomon B, Nourisson A, Colcombet-Cazenave B, Haouz A, Mechaly A, et al.
Sci Rep
. 2021 Jan;
11(1):944.
PMID: 33441627
Interactions between the hepatitis B virus core protein (HBc) and host cell proteins are poorly understood, although they may be essential for the propagation of the virus and its pathogenicity....